IMP
Process View
cd8 positive alpha beta t cell differentiation
The process in which a relatively unspecialized T cell acquires specialized features of a mature CD8-positive, alpha-beta T cell.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cd8 positive alpha beta t cell differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCL2L1 | BCL2-like 1 | 0.995 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.856 | ||
| BECN1 | beclin 1, autophagy related | 0.509 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.284 | ||
| MEOX1 | mesenchyme homeobox 1 | 0.271 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.179 | ||
| GATA4 | GATA binding protein 4 | 0.119 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.072 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.051 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.049 | ||
| UVRAG | UV radiation resistance associated gene | 0.044 | ||
| BCL2L2 | BCL2-like 2 | 0.040 | ||
| PIAS1 | protein inhibitor of activated STAT, 1 | 0.039 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.035 | ||
| PRDM1 | PR domain containing 1, with ZNF domain | 0.031 | ||
| NAF1 | nuclear assembly factor 1 homolog (S. cerevisiae) | 0.029 | ||
| IRF9 | interferon regulatory factor 9 | 0.029 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.028 | ||
| BAD | BCL2-associated agonist of cell death | 0.024 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.023 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.022 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.022 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.021 | ||
| NKG7 | natural killer cell group 7 sequence | 0.021 | ||
| BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | 0.021 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.019 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.018 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.018 | ||
| MSX1 | msh homeobox 1 | 0.016 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.016 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.016 | ||
| LBX1 | ladybird homeobox 1 | 0.016 | ||
| BBC3 | BCL2 binding component 3 | 0.015 | ||
| PPP3R1 | protein phosphatase 3, regulatory subunit B, alpha | 0.015 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.015 | ||
| GZMH | granzyme H (cathepsin G-like 2, protein h-CCPX) | 0.015 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.015 | ||
| SBNO2 | strawberry notch homolog 2 (Drosophila) | 0.014 | ||
| PML | promyelocytic leukemia | 0.014 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.014 | ||
| YAP1 | Yes-associated protein 1 | 0.014 | ||
| BID | BH3 interacting domain death agonist | 0.014 | ||
| IRF2 | interferon regulatory factor 2 | 0.013 | ||
| ZBTB20 | zinc finger and BTB domain containing 20 | 0.013 | ||
| HDAC10 | histone deacetylase 10 | 0.013 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.013 | ||
| SPNS1 | spinster homolog 1 (Drosophila) | 0.012 | ||
| MAP2K7 | mitogen-activated protein kinase kinase 7 | 0.012 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.011 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.011 | ||
| GATA5 | GATA binding protein 5 | 0.011 | ||
| MBD1 | methyl-CpG binding domain protein 1 | 0.011 | ||
| ITK | IL2-inducible T-cell kinase | 0.011 | ||
| HCRTR1 | hypocretin (orexin) receptor 1 | 0.011 | ||
| PAX3 | paired box 3 | 0.011 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.011 | ||
| NKX3-1 | NK3 homeobox 1 | 0.010 | ||
| IL15 | interleukin 15 | 0.010 | ||
| HOXC11 | homeobox C11 | 0.010 |